Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Profiting from a startup concept is achievable. Discover effective strategies that can help you unlock the potential of your ideas.
10,076 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Joby Aviation is set to report Q4 2025 results after the market close tonight. Analysts will track revenue, cash burn...
IonQ stunned traders with a sharp rally after reporting stronger-than-expected 2025 results and a robust 2026 revenue...
A lone developer demonstrates embedding an image in a single Bitcoin transaction, igniting a debate over BIP-110 data...
Curious about a long term reason to own Pfizer? This guide lays out a practical, actionable case for buying and holdi...
AI-enabled warfare is accelerating decision cycles and market risk. This report explains how Trump’s Strike Iran Bree...
A bold, high‑risk biotech bet can pay off with patience and discipline. This article breaks down iovance biotherapeut...
PRED is pushing a true peer-to-peer sports exchange model, removing the house edge and aligning trader incentives. Th...
Long-term investors are always asking which growth stocks hold next decade potential. This guide spotlights two prove...
Markets tilt away from AI hype toward real-world assets as the Great Rotation accelerates. TerraTread debuts a durabl...
A fresh, practical look at Marek Capital’s investment playbook. Discover how MiB: Matt Cherwin, Co-Founder and CIO, s...
Tech stocks lead early gains as oil eases and AI developments grab attention. The live Nasdaq Composite shows tech st...